Device-related thrombus after left atrial appendage occlusion in patients with atrial fibrillation: a prospective follow-up

Author:

Pevzner D. V.1ORCID,Omarov Y. A.1ORCID,Merkulova I. A.1ORCID,Yavelov I. S.2ORCID,Komarov A. L.1ORCID,Ganyukov V. I.3ORCID

Affiliation:

1. FSBI «National Medical Research Center for Cardiology named after academician E.I. Chazov» of the Ministry of Healthсare of the Russian Federation

2. FSBI «National Medical Research Center for Therapy and Preventive Medicine» of the Ministry of Healthсare of the Russian Federation

3. FSBI «Research Institute for Complex Issues of Cardiovascular Diseases»

Abstract

Aim. To study the incidence, predictors, and clinical outcome of device-related thrombus (DRT) after left atrial appendage occlusion (LAAO) in patients with atrial fibrillation (AF).Methods. A prospective observational study included 120 patients with non-valvular AF who underwent LAAO with Watchman (n=92) and Amplatzer Amulet (n=28). The presence of device-related thrombus (DRT) was assessed at visits 45 days, 6 months, 1 year, 2 years, 3 years after implantation by transesophageal echocardiography.Results. A total of 11 (9.2%) patients had DRT during the follow-up period. The greatest number of thrombosis was observed after 45 days (n=4) and after 6 months (n=4). There was no significant difference in the incidence of DRT between device types. Independent predictors of thrombosis were: history of myocardial infarction (hazard ratio (HR) 12.88 [95% confidence interval (CI) 3.21-51.62]; p<0.001), chronic heart failure (HR 8.83 [95% CI 1.91-40.77]; p=0.005), residual leak size >5 mm in the early postoperative period (HR 6.13 [95% CI 2.53-14.86]; p<0.001) and the degree of spontaneous echo contrast during the initial examination (HR 9.09 [95% CI 1.36-60.58], p=0.023). There were no cases of thromboembolic complications associated with DRT. One patient developed a non-fatal stroke at 35 weeks of follow-up, while DRT was detected at the visit at the end of the 3rd year of follow-up.Conclusion. DRT after LAAO was observed in the early and long-term follow-up periods. This event was associated with the baseline patients’ characteristics and post-procedural aspects with no dependence on type of antithrombotic therapy.

Publisher

Institute of Cardio Technics - INCART

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Emergency Medicine

Reference20 articles.

1. Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5): 373-498. https://doi.org/10.1093/eurheartj/ehaa612.

2. Osmancik P, Herman D, Neuzil P, et al. PRAGUE-17 Trial Investigators. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients with Atrial Fibrillation. J Am Coll Cardiol. 2020;75(25): 31223135. https://doi.org/10.1016/j.jacc.2020.04.067.

3. Pevzner DV, Merkulov EV, Arutyunyan GK, et al. Experience with various occluder types for endovascular hemodynamic isolation of the left atrium appendage in patients with non-valvular atrial fibrillation. Journal of Arrhythmology. 2021;28(3): 45-54. (In Russ.)]. https://doi.org/10.35336/VA-2021-3-45-54.

4. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EuroIntervention. 2020;15(13): 1133-1180. https://doi.org/10.4244/EIJY19M08_01.

5. Cruz-Gonzalez I, Fuertes-Barahona M, Moreno-Samos JC, et al. Left Atrial Appendage Occlusion: The Current Device Landscape and Future Perspectives. Interv Cardiol Clin. 2018;7(2): 253-265. https://doi.org/10.1016/j.iccl.2017.12.011.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3